RPG Life Sciences reported net loss of Rs 5.69 crore in the quarter ended March 2012 as against net profit of Rs 4.32 crore during the previous quarter ended March 2011. Sales declined 20.91% to Rs 41.23 crore in the quarter ended March 2012 as against Rs 52.13 crore during the previous quarter ended March 2011.
For the audited full year, net profit declined 93.31% to Rs 0.85 crore in the year ended March 2012 as against Rs 12.71 crore during the previous year ended March 2011. Sales rose 3.09% to Rs 189.23 crore in the year ended March 2012 as against Rs 183.55 crore during the previous year ended March 2011.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2012 | Mar. 2011 | % Var. | Mar. 2012 | Mar. 2011 | % Var. |
| Sales | 41.23 | 52.13 | -21 | 189.23 | 183.55 | 3 |
| OPM % | -6.43 | 18.61 | -135 | 9.59 | 17.73 | -46 |
| PBDT | -3.83 | 8.47 | PL | 11.96 | 26.99 | -56 |
| PBT | -6.43 | 6.00 | PL | 1.74 | 17.47 | -90 |
| NP | -5.69 | 4.32 | PL | 0.85 | 12.71 | -93 |